BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21408173)

  • 1. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
    Nagabhushana A; Bansal M; Swarup G
    PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.
    Zhu G; Wu CJ; Zhao Y; Ashwell JD
    Curr Biol; 2007 Aug; 17(16):1438-43. PubMed ID: 17702576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
    Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
    J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB.
    Sudhakar C; Nagabhushana A; Jain N; Swarup G
    PLoS One; 2009; 4(4):e5114. PubMed ID: 19340308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.
    Zilberman-Rudenko J; Shawver LM; Wessel AW; Luo Y; Pelletier M; Tsai WL; Lee Y; Vonortas S; Cheng L; Ashwell JD; Orange JS; Siegel RM; Hanson EP
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1612-7. PubMed ID: 26802121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
    Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
    Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.
    Wu GR; Mu TC; Gao ZX; Wang J; Sy MS; Li CY
    J Biol Chem; 2017 Nov; 292(46):18747-18759. PubMed ID: 28900035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3-14.7K is recruited to TNF-receptor 1 and blocks TNF cytolysis independent from interaction with optineurin.
    Klingseisen L; Ehrenschwender M; Heigl U; Wajant H; Hehlgans T; Schütze S; Schneider-Brachert W
    PLoS One; 2012; 7(6):e38348. PubMed ID: 22675546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis.
    Nakazawa S; Oikawa D; Ishii R; Ayaki T; Takahashi H; Takeda H; Ishitani R; Kamei K; Takeyoshi I; Kawakami H; Iwai K; Hatada I; Sawasaki T; Ito H; Nureki O; Tokunaga F
    Nat Commun; 2016 Aug; 7():12547. PubMed ID: 27552911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
    Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
    J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRP/Optineurin Cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein.
    Journo C; Filipe J; About F; Chevalier SA; Afonso PV; Brady JN; Flynn D; Tangy F; Israël A; Vidalain PO; Mahieux R; Weil R
    PLoS Pathog; 2009 Jul; 5(7):e1000521. PubMed ID: 19609363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells.
    Munitic I; Giardino Torchia ML; Meena NP; Zhu G; Li CC; Ashwell JD
    J Immunol; 2013 Dec; 191(12):6231-40. PubMed ID: 24244017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
    Sun SC
    Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
    Moquin DM; McQuade T; Chan FK
    PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation.
    Li H; Kobayashi M; Blonska M; You Y; Lin X
    J Biol Chem; 2006 May; 281(19):13636-13643. PubMed ID: 16543241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
    Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor.
    Regamey A; Hohl D; Liu JW; Roger T; Kogerman P; Toftgard R; Huber M
    J Exp Med; 2003 Dec; 198(12):1959-64. PubMed ID: 14676304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
    Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
    Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.
    Wang YB; Tan B; Mu R; Chang Y; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Li AL; Zhang XM; Li HY
    J Biol Chem; 2015 Apr; 290(16):10395-405. PubMed ID: 25681446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.